{'fraction_non_alphanumeric': 0.03523194362889019, 'fraction_numerical': 0.020551967116852612, 'mean_word_length': 5.287822878228782, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Hospital discharge on the first compared with the second day after a planned cesarean delivery: a randomized controlled trial.

may be considered in certain risk groups (eg, body mass index [BMI, calculated as weight (kg)/[height (m)]2] of 40 or more). We think these data are consistent with other reports, including our own. Recently, we looked at our institution’s experience in a retrospective case–control study. Over a period of 2 years, we identified 94 patients who underwent minimally invasive surgery for endometrial cancer, 37 of whom underwent robotic surgery. For the group, the medians were BMI 36.5 (range 19– 68.6), operative time 172 minutes (range 75–405), and estimated blood loss 200 (range 30–2000). We routinely use intraoperative intermittent pneumatic stockings and postoperative low molecular weight heparin prophylaxis in minimally invasive surgery, laparoscopy, and robotics for endometrial cancer. We monitored the patients for 1 year and found 0% incidence of venous thromboembolism. Our patient population is different from Sandadi et al’s population in terms of BMI. However, our data are not inconsistent with theirs. Their study is important as gynecologic oncology becomes more directed toward minimally invasive surgery. However, the U.S. population is becoming more obese, and, therefore, our data may be more relevant to the typical gynecologic oncology practice. We believe thromboprophylaxis should be tailored individually in different institutions according to the patient population they treat. Higher BMIs and operating room times are very important in determining postoperative prophylaxis. We use extended low molecular weight heparin in most of these cases.